Literature DB >> 34108102

Pathogenesis of psoriatic arthritis.

Carmel Stober1.   

Abstract

Psoriatic arthritis (PsA) is a heterogenous systemic inflammatory disorder which affects peripheral joints (PsA) and skin (psoriasis (Ps)), but also causes inflammation at entheseal sites, digits (dactylitis) and the axial skeleton. Over the past decade, there have been considerable advances both in our understanding of the pathogenesis of PsA and in the treatment of its diverse manifestations. This article reviews our current knowledge of the pathogenesis of PsA, and how genetic pre-disposition coupled with mechanical stress may influence the development of the pathognomonic features of PsA including enthesitis and osteoproliferation, with concomitant osteoporosis and erosive disease. We consider factors that influence the development of PsA in patients with Ps, and how improving our knowledge of the phenotypes of PsA may ultimately facilitate our goal of precision medicine, a key unmet need as defined by the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis. Crown
Copyright © 2021. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autoimmune pathogenesis; Enthesopathy; Osteoimmunology; Psoriasis; Psoriatic arthritis

Year:  2021        PMID: 34108102     DOI: 10.1016/j.berh.2021.101694

Source DB:  PubMed          Journal:  Best Pract Res Clin Rheumatol        ISSN: 1521-6942            Impact factor:   4.098


  4 in total

1.  Novel Difluorocyclohexyl Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2022-02-01       Impact factor: 4.345

2.  Novel Difluorocyclohexyl Derivatives as IL-17 Modulators for Treating Inflammatory and Autoimmune Diseases.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-11-18       Impact factor: 4.345

3.  Imidazo[1,2-b]pyridazines as IL-17A Inhibitors for Treating Psoriasis, Rheumatoid Arthritis, and Multiple Sclerosis.

Authors:  Ram W Sabnis
Journal:  ACS Med Chem Lett       Date:  2021-09-13       Impact factor: 4.632

Review 4.  Exploring the Diverse Immune and Genetic Landscape of Psoriatic Arthritis.

Authors:  Bogdan Batko
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.